176003207 - acquity CDA detector (STANDARD)
Ended Awarded
- Contract number
- HHSN26100006
- Awardee
-
Waters Technologies Corporation UEI JFT8BGF7FKV6 Part of Waters Corporation
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $55,281
Award facts
- Opportunity
-
- Scientific Equipment and Services Solicitation · 7FCBC4070066B · Posted Jun 13, 2019
- Contract value 100% obligated
- $55,280.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Fixed Price with Economic Price Adjustment
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded Waters Technologies Corporation a $55,280.73 fixed-price contract with economic price adjustment on June 27, 2014, for an ACQUITY CDA Detector (Standard) under a Blanket Purchase Agreement call structure. The contract, which completed on July 9, 2014, was performed at Research Triangle Park, North Carolina, and involved no small business set-aside designation. Waters Technologies Corporation, a subsidiary of Waters Corporation headquartered in Milford, Massachusetts, is a leading global manufacturer of advanced scientific instrumentation specializing in liquid chromatography and mass spectrometry technologies. The company supplied the detector equipment to support NCI's analytical and research capabilities through the General Services Administration's Scientific Equipment and Services Multiple Award Schedule contract vehicle.
This award reflects Waters' established market position as a primary supplier of high-precision analytical instruments to federal research agencies. The ACQUITY CDA Detector represents part of Waters' broader portfolio of ultra-high performance liquid chromatography and mass spectrometry systems regularly procured by agencies across the National Institutes of Health, including the National Cancer Institute, for sophisticated laboratory analysis supporting cancer research and regulatory testing missions. The fixed-price structure with economic price adjustment provided cost certainty while allowing for potential adjustments based on specified economic indices during the contract performance period.
Quick answers
Who was awarded contract HHSN26100006?
HHSN26100006 was awarded to Waters Technologies Corporation by National Cancer Institute (National Institutes of Health) on June 27, 2014.
How much is contract HHSN26100006 worth?
The government has obligated $55,281 on HHSN26100006.
Is contract HHSN26100006 an order under another contract?
Yes. HHSN26100006 is a BPA call under GS07F0559X-HHSN263201100088B, a blanket purchase agreement, on Scientific Equipment and Services (FSS-66).
Was contract HHSN26100006 competed?
The extent of competition for HHSN26100006 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award